Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mts362 who wrote (849)	4/5/2000 12:20:00 AM
From: rupers	Read Replies (2) of 1298

MTS - You're looking at the 10K for 1999 that was filed on March 30, 2000. The big sale occurred in Feb 2000 and couldn't be included as "earnings". Even though the 10K discussed the Feb 2000 sale, it wasn't considered earnings for 1999. Admittedly, the 10K is a little forboding and conservative. Gets me a little nervous when it emphasizes all the "risk factors" CEGE faces and the possibility of CEGE seeking additional financing options that could dilute shares. The large block of shares sold by David Broad, CEGE's Exec VP for marketing and development, in late March didn't help the price either. Should see significant swing up in price later this month or May (if not earlier).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next